nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—peripheral nervous system neoplasm	0.461	0.719	CbGaD
Neostigmine—ABCB1—peripheral nervous system neoplasm	0.18	0.282	CbGaD
Neostigmine—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0675	0.273	CbGbCtD
Neostigmine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.043	0.174	CbGbCtD
Neostigmine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.043	0.174	CbGbCtD
Neostigmine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0298	0.121	CbGbCtD
Neostigmine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0184	0.0743	CbGbCtD
Neostigmine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0171	0.0693	CbGbCtD
Neostigmine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0168	0.0681	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0115	0.0464	CbGbCtD
Neostigmine—Demecarium—BCHE—peripheral nervous system neoplasm	0.00243	0.376	CrCbGaD
Neostigmine—Pyridostigmine—BCHE—peripheral nervous system neoplasm	0.00156	0.242	CrCbGaD
Neostigmine—Edrophonium—BCHE—peripheral nervous system neoplasm	0.00128	0.198	CrCbGaD
Neostigmine—Rivastigmine—BCHE—peripheral nervous system neoplasm	0.00119	0.184	CrCbGaD
Neostigmine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000226	0.00215	CcSEcCtD
Neostigmine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000226	0.00215	CcSEcCtD
Neostigmine—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000226	0.00214	CcSEcCtD
Neostigmine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000225	0.00214	CcSEcCtD
Neostigmine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000225	0.00214	CcSEcCtD
Neostigmine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000225	0.00213	CcSEcCtD
Neostigmine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00213	CcSEcCtD
Neostigmine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00212	CcSEcCtD
Neostigmine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.0021	CcSEcCtD
Neostigmine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00022	0.00209	CcSEcCtD
Neostigmine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000219	0.00208	CcSEcCtD
Neostigmine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000219	0.00207	CcSEcCtD
Neostigmine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000219	0.00207	CcSEcCtD
Neostigmine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00206	CcSEcCtD
Neostigmine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000218	0.00206	CcSEcCtD
Neostigmine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000218	0.00206	CcSEcCtD
Neostigmine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00205	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00205	CcSEcCtD
Neostigmine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000216	0.00205	CcSEcCtD
Neostigmine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000215	0.00204	CcSEcCtD
Neostigmine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000213	0.00202	CcSEcCtD
Neostigmine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00202	CcSEcCtD
Neostigmine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000213	0.00202	CcSEcCtD
Neostigmine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00199	CcSEcCtD
Neostigmine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.00198	CcSEcCtD
Neostigmine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000207	0.00196	CcSEcCtD
Neostigmine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00195	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000205	0.00194	CcSEcCtD
Neostigmine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00194	CcSEcCtD
Neostigmine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000204	0.00194	CcSEcCtD
Neostigmine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.00193	CcSEcCtD
Neostigmine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000203	0.00192	CcSEcCtD
Neostigmine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000203	0.00192	CcSEcCtD
Neostigmine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00192	CcSEcCtD
Neostigmine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00191	CcSEcCtD
Neostigmine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000201	0.00191	CcSEcCtD
Neostigmine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0002	0.0019	CcSEcCtD
Neostigmine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000199	0.00189	CcSEcCtD
Neostigmine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00187	CcSEcCtD
Neostigmine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00187	CcSEcCtD
Neostigmine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000197	0.00187	CcSEcCtD
Neostigmine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000196	0.00186	CcSEcCtD
Neostigmine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000195	0.00185	CcSEcCtD
Neostigmine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00185	CcSEcCtD
Neostigmine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000195	0.00185	CcSEcCtD
Neostigmine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.00185	CcSEcCtD
Neostigmine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000194	0.00184	CcSEcCtD
Neostigmine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000192	0.00182	CcSEcCtD
Neostigmine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000192	0.00182	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.0018	CcSEcCtD
Neostigmine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00019	0.0018	CcSEcCtD
Neostigmine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000189	0.00179	CcSEcCtD
Neostigmine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.00179	CcSEcCtD
Neostigmine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00179	CcSEcCtD
Neostigmine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00179	CcSEcCtD
Neostigmine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000188	0.00178	CcSEcCtD
Neostigmine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.00176	CcSEcCtD
Neostigmine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000186	0.00176	CcSEcCtD
Neostigmine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00176	CcSEcCtD
Neostigmine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.00176	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000184	0.00175	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.00175	CcSEcCtD
Neostigmine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000184	0.00174	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000183	0.00174	CcSEcCtD
Neostigmine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000182	0.00173	CcSEcCtD
Neostigmine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000182	0.00173	CcSEcCtD
Neostigmine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000182	0.00172	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00171	CcSEcCtD
Neostigmine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000178	0.00169	CcSEcCtD
Neostigmine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000178	0.00169	CcSEcCtD
Neostigmine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00168	CcSEcCtD
Neostigmine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000176	0.00167	CcSEcCtD
Neostigmine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000175	0.00166	CcSEcCtD
Neostigmine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000175	0.00166	CcSEcCtD
Neostigmine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000175	0.00166	CcSEcCtD
Neostigmine—Rash—Topotecan—peripheral nervous system neoplasm	0.000175	0.00166	CcSEcCtD
Neostigmine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000175	0.00166	CcSEcCtD
Neostigmine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000174	0.00165	CcSEcCtD
Neostigmine—Headache—Topotecan—peripheral nervous system neoplasm	0.000174	0.00165	CcSEcCtD
Neostigmine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000174	0.00165	CcSEcCtD
Neostigmine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.00165	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000174	0.00165	CcSEcCtD
Neostigmine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00165	CcSEcCtD
Neostigmine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000173	0.00165	CcSEcCtD
Neostigmine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000173	0.00165	CcSEcCtD
Neostigmine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000173	0.00164	CcSEcCtD
Neostigmine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000173	0.00164	CcSEcCtD
Neostigmine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00164	CcSEcCtD
Neostigmine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000172	0.00164	CcSEcCtD
Neostigmine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000172	0.00164	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00163	CcSEcCtD
Neostigmine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000172	0.00163	CcSEcCtD
Neostigmine—Rash—Melphalan—peripheral nervous system neoplasm	0.000171	0.00163	CcSEcCtD
Neostigmine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000171	0.00162	CcSEcCtD
Neostigmine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.00162	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000169	0.0016	CcSEcCtD
Neostigmine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000166	0.00158	CcSEcCtD
Neostigmine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.00157	CcSEcCtD
Neostigmine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.00157	CcSEcCtD
Neostigmine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00156	CcSEcCtD
Neostigmine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000165	0.00156	CcSEcCtD
Neostigmine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000164	0.00156	CcSEcCtD
Neostigmine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000164	0.00155	CcSEcCtD
Neostigmine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.00155	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00155	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000163	0.00154	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000162	0.00154	CcSEcCtD
Neostigmine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000161	0.00153	CcSEcCtD
Neostigmine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000161	0.00153	CcSEcCtD
Neostigmine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000159	0.00151	CcSEcCtD
Neostigmine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000159	0.00151	CcSEcCtD
Neostigmine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.0015	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000158	0.0015	CcSEcCtD
Neostigmine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000157	0.00149	CcSEcCtD
Neostigmine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.00146	CcSEcCtD
Neostigmine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.00146	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000153	0.00146	CcSEcCtD
Neostigmine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000152	0.00144	CcSEcCtD
Neostigmine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00142	CcSEcCtD
Neostigmine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00141	CcSEcCtD
Neostigmine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000148	0.00141	CcSEcCtD
Neostigmine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.0014	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000145	0.00138	CcSEcCtD
Neostigmine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000145	0.00137	CcSEcCtD
Neostigmine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000144	0.00137	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00136	CcSEcCtD
Neostigmine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.00136	CcSEcCtD
Neostigmine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.00135	CcSEcCtD
Neostigmine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000142	0.00135	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000141	0.00133	CcSEcCtD
Neostigmine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.00131	CcSEcCtD
Neostigmine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000138	0.0013	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.0013	CcSEcCtD
Neostigmine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.00127	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000133	0.00126	CcSEcCtD
Neostigmine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000133	0.00126	CcSEcCtD
Neostigmine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.00126	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00126	CcSEcCtD
Neostigmine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.00125	CcSEcCtD
Neostigmine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.00125	CcSEcCtD
Neostigmine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00124	CcSEcCtD
Neostigmine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00124	CcSEcCtD
Neostigmine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.00124	CcSEcCtD
Neostigmine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000129	0.00123	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000129	0.00122	CcSEcCtD
Neostigmine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000128	0.00121	CcSEcCtD
Neostigmine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000128	0.00121	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.0012	CcSEcCtD
Neostigmine—Rash—Vincristine—peripheral nervous system neoplasm	0.000127	0.0012	CcSEcCtD
Neostigmine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000127	0.0012	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.0012	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00119	CcSEcCtD
Neostigmine—Headache—Vincristine—peripheral nervous system neoplasm	0.000126	0.00119	CcSEcCtD
Neostigmine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.00118	CcSEcCtD
Neostigmine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000122	0.00115	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00115	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00012	0.00114	CcSEcCtD
Neostigmine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000119	0.00113	CcSEcCtD
Neostigmine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00113	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00111	CcSEcCtD
Neostigmine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000117	0.00111	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00111	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00111	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000116	0.0011	CcSEcCtD
Neostigmine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000115	0.00109	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00109	CcSEcCtD
Neostigmine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000113	0.00107	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00107	CcSEcCtD
Neostigmine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000112	0.00106	CcSEcCtD
Neostigmine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000112	0.00106	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000111	0.00106	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00105	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00105	CcSEcCtD
Neostigmine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000108	0.00102	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00102	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00102	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00101	CcSEcCtD
Neostigmine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000106	0.001	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000988	CcSEcCtD
Neostigmine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000104	0.000982	CcSEcCtD
Neostigmine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000975	CcSEcCtD
Neostigmine—Rash—Etoposide—peripheral nervous system neoplasm	0.000103	0.000974	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000103	0.000973	CcSEcCtD
Neostigmine—Headache—Etoposide—peripheral nervous system neoplasm	0.000102	0.000968	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000967	CcSEcCtD
Neostigmine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000952	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000944	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000933	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000919	CcSEcCtD
Neostigmine—Nausea—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.000918	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000903	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000902	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000897	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000883	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.00088	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000866	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000863	CcSEcCtD
Neostigmine—Shock—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000852	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000851	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000849	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000845	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000841	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.000837	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000836	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.00083	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000817	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000809	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000801	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000789	CcSEcCtD
Neostigmine—Shock—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000788	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000786	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000783	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000782	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000778	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000775	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000772	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.00077	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000749	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000748	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.00073	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000725	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000714	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000712	CcSEcCtD
Neostigmine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000708	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000692	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.25e-05	0.000688	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000685	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000655	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000638	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.000637	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000633	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000621	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000613	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.25e-05	0.000593	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.00059	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000575	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000573	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000567	CcSEcCtD
Neostigmine—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000551	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	0.000548	CcSEcCtD
Neostigmine—Rash—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000546	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000546	CcSEcCtD
Neostigmine—Headache—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000543	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.00053	CcSEcCtD
Neostigmine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000514	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000509	CcSEcCtD
Neostigmine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000505	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000505	CcSEcCtD
Neostigmine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000502	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000476	CcSEcCtD
